Showing results (81-90 of 144) with videos related to
Sort By:
Pageof 15
Oncology Reports|November 27, 2010
Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cellsAlexandra Wendler, Daniela Keller, Christian Albrecht, et al.The International Journal of Biochemistry & Cell Biology|May 19, 2004
Porcine spermatozoa contain more than one membrane progesterone receptorRalf Lösel, Alexandra Dorn-Beineke, Elisabeth Falkenstein, et al.Current Opinion in Allergy and Clinical Immunology|February 13, 2003
Novel approaches in the treatment of allergic rhinitisArmin Schultz, Boris Alexander Stuck, Martin Feuring, et al.Zeitschrift Fur Gerontologie Und Geriatrie|February 11, 2016
[New oral anticoagulants for prophylaxis of stroke. Results of an expert conference on practical use in geriatric patients]Philipp Bahrmann, Fred Harms, Christian Martin Schambeck, et al.Deutsche Medizinische Wochenschrift (1946)|August 26, 2015
[Renal impairment in patients with thromboembolic event: prevalence and clinical implications. A systematic review of the literature]Thomas Wilke, Martin Wehling, Steffen Amann, et al.Journal of Thrombosis and Thrombolysis|August 4, 2011
Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variabilityJob Harenberg, Roland Krämer, Christina Giese, et al.Journal of Thrombosis and Thrombolysis|November 14, 2013
Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countriesMartin Krejczy, Job Harenberg, Svetlana Marx, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
Patients' serum and urine as easily accessible samples for the measurement of non-vitamin K antagonist oral anticoagulantsJob Harenberg, Shanshan Du, Sandra Krämer, et al.Diabetes|July 30, 2002
Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatinMichael Christ, Johann Bauersachs, Claudia Liebetrau, et al.Therapeutic Drug Monitoring|December 20, 2014
Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation MethodShanshan Du, Job Harenberg, Sandra Krämer, et al.Pageof 15